A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of PF-07275315 and PF-07264660 in Adult Participants With Moderate-Severe Atopic Dermatitis

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Daniel Butler
Sponsor
Pfizer, Incorporated
Unit
Medicine